InvestorsHub Logo
Followers 155
Posts 2642
Boards Moderated 0
Alias Born 01/29/2004

Re: powerwalker post# 439495

Monday, 11/20/2023 2:58:51 PM

Monday, November 20, 2023 2:58:51 PM

Post# of 462198
Yes, the Story Will Be Global

falconer, you should add UK, too. It is closely tied to Australia and would probably be tied to a TGA submission. Also, I think some Rett ped participants were in UK.


Thank you. Indeed. The UK is another blarcamesine market I should have included.

But, so then, too, would be Japan. China is gigantic, but it's adherence to intellectual and financial property rights is always questionable; not a place Anavex would desire to engage right off.

The wider view, global, in fact, is that Anavex's proprietary sigma-1 receptor agonists (activators) will eventually have therapeutic and prophylactic applications for all human populations. Each reader, from his own determining diligence, will have to determine the validity of that perspective. The greatest medical treatment advances in the 20th century were antibiotics and associated public hygiene practices. They changed profoundly the way diseases were treated or prevented. In this century, but far more profoundly, it will be Anavex's sigma-1 receptor agonists.

And we can all say we were there at the beginning; closely watching the story develop from its meager start.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News